We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.


Adipose Dysfunction, Imaging, Physiology, and Outcomes with SGLT2i’s for Sleep Apnea

man sleeping
AGE: 18+ years old
TYPE: Interventional Study
CONDITION: Sleep Apnea
LOCATIONS: UH Cleveland Medical Center

Learn more about this research study

Please contact the study coordinator, Joseph Rutter, at 216-286-5025 for more information or complete the online form below.

Purpose of Study

The purpose of the study is to evaluate the effectiveness of an investigative medication, bexagliflozin, for obstructive sleep apnea (OSA).

Who Can Participate?

Participants 18 years and older that are overweight or obese (body mass index 25-40 kg/m2) and have a clinically confirmed diagnosis of obstructive sleep apnea may be eligible for this study.

Study Details

The study participation will last approximately six months with five visits to the hospital. These visits will take about 12-hours total. Study procedures will include sleep studies, questionnaires, two MRI scans, wearing an activity tracker, blood pressure monitoring, and laboratory tests.

Request More Information

To learn more about this study, please fill out the form below to request more information.

I'm not a robot